| Quarterly Financials | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 97 | 102 | 77 | 80 | 89 | 73 | 57 |
| Expenses | 90 | 91 | 68 | 71 | 80 | 63 | 62 |
| EBITDA | 7 | 12 | 8 | 9 | 9 | 10 | -5 |
| Operating Profit % | 7 % | 11 % | 11 % | 11 % | 10 % | 14 % | -8 % |
| Depreciation | 4 | 4 | 4 | 4 | 4 | 5 | 5 |
| Interest | 3 | 4 | 4 | 4 | 4 | 4 | 4 |
| Profit Before Tax | 0 | 4 | 1 | 1 | 1 | 2 | -13 |
| Tax | -1 | 0 | -2 | -2 | 0 | 2 | 1 |
| Net Profit | 1 | 4 | 3 | 3 | 1 | 0 | -14 |
| EPS in ₹ | 0.31 | 2.23 | 1.70 | 1.70 | 0.81 | 0.04 | -8.72 |
Mangalam Drugs & Organics
Mangalam Drugs & Organics
71.46
-0.17
(-0.24%)
There are new updates from the company22 hours ago
View
Market Cap
113.40 Cr
EPS
4.25
PE Ratio
19.67
Dividend Yield
0.00 %
Industry
Healthcare52 Week High
130.85
52 Week Low
70.10
PB Ratio
0.79
Debt to Equity
0.73
Sector
Pharmaceuticals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Company News
View All News
Mangalam Drugs & Organics Unsecured Creditors Approve Merger Scheme with 98.46% Majority
Aug 14, 2025
Aug 14, 2025Mangalam Drugs & Organics Limited held a Tribunal Convened Meeting of unsecured creditors on August 12, 2025, via video conferencing to vote on a merger resolution. The meeting approved the Scheme of Merger by Absorption of Mangalam Laboratories Private Limited and Shri JB Pharma Private Limited with Mangalam Drugs and Organics Limited. Out of 80 total unsecured creditors as of the December 31, 2024 cut-off date, 36 attended the meeting. The voting results showed 37 creditors with a value of ₹27.38 crore (98.46%) voted in favor, while 1 creditor with a value of ₹0.43 crore (1.54%) voted against the resolution. The e-voting facility was provided through remote voting and during the meeting. Venugopal Prasad Rao was appointed as scrutinizer by the NCLT Mumbai Bench. The resolution was declared passed with the requisite majority.
Mangalam Drugs & Organics Holds Tribunal Meetings to Approve Merger SchemeAug 12, 2025
Mangalam Drugs & Organics Limited conducted two tribunal-convened meetings on August 12, 2025, to approve a merger scheme. The unsecured creditors meeting ran from 11:05 AM to 11:27 AM, while the equity shareholders meeting was held from 12:39 PM to 1:05 PM, both via video conferencing. The meetings sought approval for the merger by absorption of Mangalam Laboratories Private Limited and Shri JB Pharma Private Limited with Mangalam Drugs and Organics Limited. The meetings were held pursuant to an NCLT Mumbai order dated June 30, 2025. Remote e-voting facilities were provided through NSDL, with voting lines remaining open for 30 minutes post-meeting conclusion. Scrutinizer Venugopal Prasad Rao will submit consolidated voting results to stock exchanges within prescribed timelines.
Mangalam Drugs Reports Rs 1,372.80 Lakh Net Loss in Q1 2025Aug 07, 2025
Mangalam Drugs & Organics Limited reported a net loss of Rs 1,372.80 lakh for the quarter ended June 30, 2025, compared to a net profit of Rs 268.47 lakh in the same quarter last year. Revenue from operations declined to Rs 5,734.87 lakh from Rs 7,653.62 lakh year-over-year. The company's earnings per share dropped to negative Rs 8.67 from positive Rs 1.70 in the previous year quarter. Total expenses increased to Rs 6,623.26 lakh. The company operates in manufacturing of bulk drugs segment. A merger scheme involving Mangalam Laboratories Private Limited and Shri JB Pharma Private Limited is pending approval from the National Company Law Tribunal, with creditor and shareholder meetings scheduled for August 12, 2025.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,636.20 | #1 3,82,526.00 | 34.22 | #1 54,729.00 | 9.71 | #1 10,980 | -19.84 | 43.29 | |
5,710.00 | 1,51,038.30 | 65.74 | 9,712.00 | 18.67 | 2,191 | 26.74 | 28.97 | |
3,567.10 | 1,21,948.70 | 59.71 | 11,539.40 | 6.99 | 1,911 | 19.91 | 51.91 | |
1,513.00 | 1,21,429.70 | 22.68 | 28,409.50 | 7.12 | 5,291 | 9.88 | 39.80 | |
1,244.70 | 1,02,131.70 | #1 18.31 | 33,741.20 | 16.73 | 5,725 | 1.26 | 34.86 | |
2,439.60 | 1,00,535.60 | 53.25 | 12,744.20 | #1 20.90 | 2,007 | -18.14 | 34.79 | |
991.15 | 98,802.10 | 21.41 | 23,511.00 | 18.55 | 4,615 | 2.60 | 40.31 | |
1,981.30 | 87,299.50 | 24.47 | 22,909.50 | 13.74 | 3,306 | #1 51.64 | 38.96 | |
5,459.50 | 64,864.00 | 28.71 | 13,458.30 | 3.70 | 2,216 | 21.39 | 52.88 | |
1,086.00 | 62,953.10 | 18.78 | 32,345.60 | 9.43 | 3,484 | -10.24 | 49.39 |
Forecast
Actual
Growth Rate
Revenue Growth
-13.56 %
Net Income Growth
-173.63 %
Cash Flow Change
989.26 %
ROE
-167.51 %
ROCE
571.43 %
EBITDA Margin (Avg.)
-32.41 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2024 | 2025 |
| Total Assets | 334 | 366 |
| Fixed Assets | 148 | 163 |
| Current Assets | 176 | 199 |
| Capital Work in Progress | 8 | 3 |
| Investments | 0 | 0 |
| Other Assets | 178 | 201 |
| Total Liabilities | 334 | 366 |
| Current Liabilities | 164 | 192 |
| Non Current Liabilities | 34 | 26 |
| Total Equity | 136 | 149 |
| Reserve & Surplus | 120 | 133 |
| Share Capital | 16 | 16 |
Cash Flow
| Cash Flow | 2024 | 2025 |
| Net Cash Flow | -3 | 1 |
| Investing Activities | -12 | -20 |
| Operating Activities | 4 | 43 |
| Financing Activities | 5 | -22 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 50.53 % | 50.53 % | 50.53 % | 50.53 % | 50.53 % | 50.42 % | 50.42 % | 50.32 % | 50.32 % | 50.32 % | 50.32 % | 50.32 % | 50.32 % | 50.32 % | 50.30 % | 50.30 % | 50.30 % | 50.30 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.10 % | 0.26 % | 0.21 % | 0.11 % | 0.11 % | 0.47 % | 0.53 % |
| DIIs | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 44.27 % | 42.68 % | 44.53 % | 44.39 % | 43.85 % | 44.18 % | 44.12 % | 44.27 % | 44.22 % | 44.64 % | 44.54 % | 44.43 % | 44.22 % | 44.70 % | 44.91 % | 44.78 % | 44.55 % | 44.53 % |
| Others | 5.19 % | 6.78 % | 4.93 % | 5.07 % | 5.61 % | 5.40 % | 5.46 % | 5.41 % | 5.46 % | 5.05 % | 5.14 % | 5.15 % | 5.20 % | 4.77 % | 4.67 % | 4.80 % | 4.68 % | 4.63 % |
| No of Share Holders | 0 | 20,520 | 21,827 | 21,071 | 20,668 | 20,084 | 18,988 | 18,483 | 17,943 | 17,890 | 17,978 | 18,610 | 19,173 | 19,312 | 19,508 | 19,679 | 19,697 | 19,728 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.92 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 26 Sept 2024 |  Annual General Meeting | NA | 26 Sept 2024 | 130.33 | 124.37 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 110.36 | 105.03 |
| 13 Feb 2025 | Quarterly Result Announcement | NA | 13 Feb 2025 | 109.00 | 110.75 |
| 17 May 2025 | Quarterly Result Announcement | NA | 17 May 2025 | 78.66 | 82.30 |
| 07 Aug 2025 | Quarterly Result Announcement | NA | 07 Aug 2025 | 87.56 | 84.03 |
| 12 Aug 2025 |  Extraordinary General Meeting | NA | 12 Aug 2025 | 85.56 | 77.13 |
| 29 Sept 2025 | Annual General Meeting | NA | 29 Sept 2025 | 78.43 | 72.22 |
Announcements
Shareholder Meeting / Postal Ballot-Scrutinizers Report22 hours ago
22 hours agoAnnouncement under Regulation 30 (LODR)-Change in Management1 day ago
1 day agoClosure of Trading Window2 days ago
2 days agoShareholder Meeting / Postal Ballot-Outcome of AGM2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Newspaper PublicationSep 19, 2025
Sep 19, 2025Announcement Under Regulation 30 Of SEBI(LODR)Regulations 2015 For Submission Of Corrigendum For 52Nd Annual Report Of 2024-25.Sep 19, 2025
Sep 19, 2025Reg. 34 (1) Annual Report.Sep 10, 2025
Sep 10, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 09, 2025
Sep 09, 2025Intimation Of 52Nd Annual General Meeting Of The Company To Be Held On 29Th September 2025 At 3:00 P.M. Through Video Conferencing/ Other Audio Visual Means.Sep 07, 2025
Sep 07, 2025Reg. 34 (1) Annual Report.Sep 07, 2025
Sep 07, 2025Appointment Of Ragini Chokshi & Co. As Secretarial Auditor Of The Company For The Period Of 5 Years Commencing From 1St April 2025 Till 31St March 2030 Subject To Approval Of Shareholders.Sep 05, 2025
Sep 05, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 5Th Sepetember 2025 For Appointment Of Secretarial Auditor Appointment For A Period Of Five Years Subject To Approval Of Shareholders In The Upcoming Annual General Meeting.Sep 05, 2025
Sep 05, 2025Board Meeting Intimation for Board Meeting Intimation To Be Held On 5Th September 2025 Inter Alia To Approve Appointment Of Secretarial Auditor For The Period Of 5 Years And Re-Appointment Of Director Who Is Retiring By Rotation.Aug 28, 2025
Aug 28, 2025Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderAug 22, 2025
Aug 22, 2025Intimation Of Voting Results And Scrutinizers Report Of Tribunal Convened Equity Shareholders Meeting Held On 12Th August 2025 At 12.30 P.M.Aug 14, 2025
Aug 14, 2025Intimation Of The Voting Results And Scrutinizers Report For The Tribunal Convened Unsecured Creditors Meeting Held On 12Th August 2025 At 11:00 A.M.Aug 14, 2025
Aug 14, 2025Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Aug 13, 2025
Aug 13, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Aug 13, 2025
Aug 13, 2025Shareholder Meeting / Postal Ballot-Outcome of Court Convened MeetingAug 12, 2025
Aug 12, 2025Shareholder Meeting / Postal Ballot-Outcome of Court Convened MeetingAug 12, 2025
Aug 12, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 08, 2025
Aug 08, 2025Approval Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended 30Th June 2025Aug 07, 2025
Aug 07, 2025Approval Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended 30Th June 2025Aug 07, 2025
Aug 07, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 7Th August 2025 For The Unaudited Financial Results For The Quarter Ending June 2025Aug 07, 2025
Aug 07, 2025Board Meeting Intimation for Notice Of Board Meeting For Approval Of Unaudited Financial Results For 1St Quarter Ending Of 2025-26 To Be Held On 7Th August 2025 At 4:00 P.M.Jul 30, 2025
Jul 30, 2025Intimation Of Notice Of Tribunal Convened Meeting Of Unsecured To Be Held On 12Th August 2025 At 11:00 A.M.Jul 12, 2025
Jul 12, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 12, 2025
Jul 12, 2025Notice Of Tribunal Convened Meeting Of Shareholders To Be Held On 12Th August 2025 At 12:30 P.M.Jul 12, 2025
Jul 12, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 09, 2025
Jul 09, 2025Corporate Action-Updates on Amalgamation/ Merger / DemergerJul 09, 2025
Jul 09, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
May 30, 2025Board Meeting Outcome for Revised Outcome Of Board Meeting Held On 17Th May 2025 Inter- Alia To Approve Audited Financial Results For The Quarter And Year Ended 31St March 2025.May 30, 2025
May 30, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 19, 2025
May 19, 2025Approval Of Financial Results For The Quarter And Year Ended 31St March 2025May 17, 2025
May 17, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 17Th May 2025 At 5:00 P.M. To Approve Audited Financial Results Of The Company For The Quarter And Year Ended 31St March 2025May 17, 2025
May 17, 2025Board Meeting Intimation for Approval Of Audited Financial Results(Standalone And Consolidated) For The Quarter And Year Ended 31St March 2025May 14, 2025
May 14, 2025Announcement under Regulation 30 (LODR)-Change in ManagementApr 11, 2025
Apr 11, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 11Th April 2025 At 2:00 P.M.Apr 11, 2025
Apr 11, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2025
Apr 09, 2025Regulatory Update As Per Regulation 31(4) Of Substantial Acquisition Of Shares And Takeover Regulations 2011Apr 07, 2025
Apr 07, 2025Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 11Th April 2025 To Approve Appointment Of Chief Financial Officer Of The Company W.E.F. 11Th April 2025Apr 04, 2025
Apr 04, 2025Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Mar 29, 2025
Mar 29, 2025Board Meeting Outcome for Outcome Board Meeting Held On 29Th March 2025 For Acceptance Of The Resignation Tendered By Chief Financial Officer Of The Company W.E.F. 31St March 2025Mar 29, 2025
Mar 29, 2025Closure of Trading WindowMar 28, 2025
Mar 28, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Mar 06, 2025
Mar 06, 2025Integrated Filing (Financial)Feb 25, 2025
Feb 25, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 15, 2025
Feb 15, 2025Declaration Of Un-Audited Financial Results For The Quarter Ended 31St December 2024Feb 13, 2025
Feb 13, 2025Board Meeting Outcome for Declaration Of Un-Audited Financial Results For The Quarter Ended 31St December 2024Feb 13, 2025
Feb 13, 2025Technical Indicators
RSI(14)
Neutral 32.62
ATR(14)
Volatile 2.94
STOCH(9,6)
Oversold 17.68
STOCH RSI(14)
Oversold 8.21
MACD(12,26)
Bearish -0.17
ADX(14)
Weak Trend 12.62
UO(9)
Bearish 33.49
ROC(12)
Downtrend And Accelerating -5.16
WillR(14)
Oversold -84.60
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
